

In The Times, the Tempus column kicks off with animal semen producer Genus, which dropped yesterday as investors worried about the price of feedstocks...


While the miners were dominating the downward trend on the second-tier FTSE 250 index on Tuesday afternoon, there were a handful of outperformers, mos...


- Investors in 'wait and see mode' ahead of ECB - Markets await pivotal US ISM data - Moody's lower EU outlook to 'negative' The FTSE 100 had slumped...


Ashtead: Jefferies lifts target from 360p to 320p, buy rating kept. Barclays: JP Morgan downgrades to neutral from overweight, target cut from 265p t...


- Moody's lower EU rating to 'negative' - Markets await US ISM data - Investors keep eyes pinned on ECB UK stocks pulled back on Tuesday morning foll...


The veterinary pharmaceuticals firm Dechra has revealed growing sales across all its major brands and profits ahead of market forecasts for the full y...


Tuesday has a bit of an agricultural feel to it, with animal genetics company Genus and veterinary health-care company Dechra Pharmaceuticals set to u...


Central bank decisions will be in focus next week, particularly in the wake of the central bankers' economic symposium in Jackson Hole. Indeed, so bu...